medigraphic.com
ISSN 1561-2996 (Electronic)
ISSN 0864-0289 (Print)

2015, Number 2

<< Back Next >>

Rev Cubana Hematol Inmunol Hemoter 2015; 31 (2)

Cold agglutinins syndrome and autoimmune thrombocytopenic purpura. An unusual case of Evans syndrome

Alfonso VME, Bencomo HA, Hernández PC, Avila COM

Language: Spanish
References: 32
Page: 195-203
PDF size: 99.18 Kb.


ABSTRACT

Evans syndrome is a rare disorder in which thrombocytopenia and anemia are observed, both of autoimmune aetiology, which may occur simultaneously or successively. A rare case of cold autoimmune hemolytic anemia associated to autoimmune thrombocytopenic purpura is presented. A 22-year-old female patient with diagnosis of autoimmune thrombocytopenic purpura, after 7 years of evolution and one year in remission, has a cold autoimmune hemolytic anemia, refractory to steroid treatment and vinca alkaloids, which requires transfusions of packed erythrocytes and achieves remission with anti CD 20 monoclonal antibody. The remaining studies of autoimmunity are negative. Currently the patient is asymptomatic and without immunosuppressive therapy.


REFERENCES

  1. Muñiz E, Canals C, Nogués N. Anemia hemolítica autoinmune y transfusión En: Cortés A, León G, Muñoz M, Jaramillo S, Eds. Aplicaciones y práctica de la Medicina Transfusional. 1a ed. Santiago de Cali: GCIAMT;2012. p.135-752.

  2. Murphy MF, Stanworth SJ. Haematological disease. En: Michael F, Murphy MF, Pamphilon DH, ed. Transfusion Medicine. 2nd ed. Oxford: Wiley-Blackwell; 2005. p.119-31.

  3. Petz LD. Cold antibody autoimmune hemolytic anemias. Blood Rev. 2008;22:1–15.

  4. Berentsen S, Tjønnfjord GE. Diagnosis and treatment of cold agglutinin mediated autoimmune hemolytic anemia. Blood Rev. 2012;26:107–15.

  5. Wright DE, Rosovsky RP, Platt MY. Case 36-2013: A 38-Year-Old Woman with Anemia and Thrombocytopenia. N Engl J Med. 2013;369 (21):2032-43.

  6. Evans RS, Duane RT. Acquired hemolytic anemia; the relation of erythrocyte antibody production to activity of the disease; the significance of thrombocytopenia and leukopenia. Blood. 1949;4:1196-213.

  7. Evans RS, Takahashi K, Duane RT, Payne R, Liu C. Primary thrombocytopenic purpura and acquired hemolytic anemia: evidence for a common etiology. AMA Arch Intern Med. 1951;87:48-65.

  8. Michel M, Chanet V, Dechartres A, Morin AS, Piette JC, Cirasino L, et al. The spectrum of Evans syndrome in adults: new insight into the disease based on the analysis of 68 cases. Blood. 2009 Oct;114(15):3167-72.

  9. Romero A, Gil M, Ortiz A, Tamayo M, Felinciano V, Suárez JC, et al. Síndrome de Evans Fisher asociado con esclerodermia. Revista Cubana de Hematol, Inmunol Hemoter. 2014;30(1):81-8.

  10. Seidel MG. Autoimmune and other cytopenias in primary immunodeficiencies: pathomechanisms, novel differential diagnoses, and treatment. Blood. 2014 Oct;124(15):2337-44.

  11. Berentsen S. How I manage cold agglutinin disease. Br J Haematol. 2011;153(3):309–17.

  12. Nydegger UE, Kazatchkine MD, Miescher PA. Immunopathologic and clinical features of hemolytic anemia due to cold agglutinins. Seminars Hematol. 1991;28:66–77.

  13. Dacie JV. Auto-immune haemolytic anaemia (AIHA): cold antibody syndromes. I: idiopathic types: clinical presentation and haematological and serological findings. En: The Haemolytic Anaemias. 3rd ed. New York: Churchill Livingstone; 1992. p. 210–39.

  14. Schubothe H. The cold hemagglutinin disease. Semin Hematol. 1966;3:27–47.

  15. Seldon M, Isbister JP, Raik E, Biggs JC. A fatal case of cold autoimmune hemolytic anemia. Am J Clin Pathol. 1980;73:716–7.

  16. Rousey SR, Smith RE. A fatal case of low titer anti-PR cold agglutinin disease. Am J Hematol. 1990;35:286–7.

  17. Leddy JP, Swisher SN. Acquired Immune Hemolytic Disorders (Including Drug- Induced Immune Hemolytic Anemia). In: Samter M, ed. Immunologic Diseases. 3 ed. Boston: Little Brown & Co;1978. p.1187.

  18. Schreiber AD, Herskovitz BS, Goldwein M. Low-titer coldhemagglutinin disease. Mechanism of hemolysis and response to corticosteroids. N Engl J Med. 1977;296:1490–4.

  19. Perez O, Reyes OI, Forero ED. Anemia hemolítica por aglutininas frías y púrpura trombocitopénica inmune: presentación no usual del síndrome de Evans?. Resúmenes XXII Congreso Colombiano de Medicina Interna. Acta Médica Colombiana. 2012 oct-dic;37(4):113-39.

  20. Rosse WF. Correlation of in vivo and in vitro measurements of hemolysis in hemolytic anemia due to immune reactions. Prog Hematol. 1973;8:51–75.

  21. Lopez J. Presentation of case. N Engl J Med 2013;369:2032-43.

  22. Yoshimura T, Nakane T, Kamesaki T, Inaba A, Nishimoto M, Mukai S, et al. Diffuse large B-cell lymphoma with hemolytic crisis developed twenty years after the onset of Evans syndrome. Rinsho Ketsueki. 2014 May;55(5):546-51.

  23. Bussone G, Ribeiro E, Dechartres A, Viallard JF, Bonnotte B, Fain O, et al. Efficacy and safety of rituximab in adults’ warm antibody autoimmune haemolytic anemia: retrospective analysis of 27 cases. Am J Hematol. 2009;84:153-7.

  24. Dierickx D, Verhoef G, Van Hoof A, Mineur P, Roest A, Triffet A, et al. Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric study. J Intern Med. 2009 Nov;266:484-91.

  25. Pescovitz MD. Rituximab, and anti-CD20 monoclonal antibody: history and mechanism of action. Am J Transplant. 2006;6:859–66.

  26. Lee E, Zamkoff KW, Gentile TC, Zimrin A. Rituxan in the treatment of autoimmune hemolytic anemia (AIHA). Blood. 2000;96:596a–7a.

  27. Berentsen S, Tjonnfjord GE, Gjertsen BT, Hammerstron J, Langholm R, Sorbo JH. Rituxan (Rituximab) therapy for chronic cold agglutinin disease. Blood. 2000;96:524a.

  28. Berentsen S, Tjonnfjord GE, Brudevold R, Gjertsen BT, Langholm R, Løkkevik E, et al. Favourable response to therapy with the anti-CD20 monoclonal antibody rituximab in primary chronic cold agglutinin disease. Br J Haematol.2001 Oct;115:79–83.

  29. Zanella A, Barcellini W. Treatment of autoimmune hemolytic anemias. Haematologica. 2014 Oct;99(10):1547–54.

  30. Malesci D, La Montagna G. Occurrence of cold agglutinin disease in RA patient during etanercept therapy successfully treated with rituximab. F. Rheumatology 2008; 7(5):734-5.

  31. Stasi R. Rituximab in autoimmune hematologic diseases: not just a matter of B cells. Semin Hematol . 2010 Apr;47(2):170-9.

  32. Berentsen S, Randen U, Vågan AM, Hjorth-Hansen H, Vik A, Dalgaard J, et al. High response rate and durable remissions following fludarabine and rituximab combination therapy for chronic cold agglutinin disease. Blood. 2010 Oct, 116 (17):3180-4. doi: 10.1182/blood-2010-06-288647.




2020     |     www.medigraphic.com